Raytheon Technologies: a safe stock for an unsafe world
Defence spending is set to soar – that should be good news for aerospace heavyweight Raytheon Technologies.
Russia’s invasion of Ukraine has alerted democracies to the dangers of dictators with expansionist ambitions. The results will include strengthening of protective alliances and increased spending on defence. Germany, which has long undershot the Nato target of 2% GDP on defence, is now preparing to exceed that. Japan, which is conscious of China’s threats to invade democratic Taiwan and the South China Sea islands, has set a record defence budget for 2022. Australia is increasing its defence force by one-third.
Defence companies are thus likely to see sustained growth in orders. I recommended Lockheed Martin, the world’s largest defence company, in June 2020 (up around 22% since) and I am now recommending the world’s second-largest defence company – Raytheon Technologies (NYSE: RTX), which was formed by the merger of Raytheon and United Technologies in April 2020.
A wide range of products
Defence accounts for 65% of Raytheon’s sales, and this is likely to increase.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group has four divisions: Pratt & Whitney produces commercial and military aero-engines. Key products include engines for the Airbus A320neo and A220 airliners, the F-35 and F-16 fighters, Apache helicopters and research on high-speed military engines.
Missiles & Defence makes the Patriot anti-missile systems (the world’s primary land-based system), naval missiles, hypersonic missiles, space sensors to detect missile launches, radars, and command and control systems.
Collins Aerospace makes aerospace avionics, structures and systems for Airbus, Boeing, Lockheed, Embraer and Dassault and for US submarines and destroyers.
Intelligence & Space, which again serves both military and commercial customers, covers airspace modernisation (surveillance, navigation, landing systems), battle management (command and control, land and satellite surveillance, electronic warfare planning and management) and hardening information systems against cyberattacks.
Developing new technologies
Raytheon’s research and development is focusing on areas including cyber-hardened connected systems (both commercial and battlespace), autonomy and artificial intelligence (unmanned aircraft, autonomous and semi-autonomous operations), propulsion (more sustainable commercial engines, next-generation military aircraft, hypersonics) and precision sensing and effects (space sensing, missiles and missile defence, directed energy weapons, electronic warfare). There are usually over 300 new ideas under assessment, with some gaining defence or commercial contracts.
Recent wins include a contract from the US Missile Defence Agency to develop and test the first interceptor to defeat hypersonic missile threats from Russia and China; an electro-optical system giving F-35 pilots an unprecedented 360-degree situational awareness and survivability; a joint Lockheed/Raytheon contract to build an Australian missile factory to counter threats from China; and a US Department of Energy contract to develop hydrogen propulsion technology for zero in-flight CO2 emissions, up to 80% reduction in NOx emissions and up to 35% reduction in fuel consumption.
Raytheon has a wide moat against competition based on extensive engineering know-how and close relationships with defence procurement agencies. Its products have high switching costs: long-term defence contracts typically have upgrade programmes to extend products’ lives, with substantial after-market sales. Investors get a company in a very strong position, trading on attractive valuations (see below) and with the prospect of upwards earnings revisions for the coming years if further orders come in as defence spending increases around the world.
Raytheon Technologies: a behemoth with room to grow
The Raytheon-United Technologies merger in 2020 was the biggest ever in the sector, creating a focused aerospace and defence behemoth from two firms that previously grew both organically and through smaller deals in recent years. Acquisitions included cybersecurity firms Websense and Foreground Security in 2015, Rockwell Collins in 2018, Blue Canyon Technologies, a satellite provider, in 2020 and, in 2021, FlightAware (the world���s largest flight-tracking and data platform) and SEAKR Engineering (a space electronics company).
The post-merger Raytheon reported sales of $64.4bn in 2021, up 13.8% from 2020. The company also achieved an extra $760m of synergies from the merger, taking the total to $1bn. Operating profit was $5bn, but adjusted operating profit (ie, excluding acquisition accounting adjustments) was $7.3bn. Earnings per share (EPS) was $2.6, but $4.3 on an adjusted basis. The company’s guidance for 2022 is for EPS of $4.6 to $4.8 and free cash flow of $6bn, up 20%. The 2025 targets are for a compound annual growth rate in sales of 6%-7%, expanding margins and free cash flow of at least $10bn.
Analysts’ average estimates for EPS are $4.79 for 2022, rising to $5.81 for 2023 and $6.71 for 2024. At the recent price of $103, these EPS figures give a forward price/earnings (p/e) ratio of 21.5 for 2022, falling to 17.7 for 2023 and 15.4 for 2024. However, Raytheon’s guidance was set out in January, before Russia’s invasion of Ukraine. Thus earnings could rise more (and valuations be cheaper) if the general upgrade of Western countries’ defences results in further orders.
Raytheon’s current dividend is $2.04 per share, which gives a reasonable yield of 2%. Share buybacks ($2.3bn in 2021) also support the share price. The first-quarter results are due on 26 April.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Highly qualified (BSc PhD CPhys FInstP MIoD) expert in R&D management, business improvement and investment analysis, Dr Mike Tubbs worked for decades on the 'inside' of corporate giants such as Xerox, Battelle and Lucas. Working in the research and development departments, he learnt what became the key to his investing; knowledge which gave him a unique perspective on the stock markets.
Dr Tubbs went on to create the R&D Scorecard which was presented annually to the Department of Trade & Industry and the European Commission. It was a guide for European businesses on how to improve prospects using correctly applied research and development. He has been a contributor to MoneyWeek for many years, with a particular focus on R&D-driven growth companies.
-
Christmas at Chatsworth: review of The Cavendish Hotel at Baslow
MoneyWeek Travel Matthew Partridge gets into the festive spirit at The Cavendish Hotel at Baslow and the Christmas market at Chatsworth
By Dr Matthew Partridge Published
-
Tycoon Truong My Lan on death row over world’s biggest bank fraud
Property tycoon Truong My Lan has been found guilty of a corruption scandal that dwarfs Malaysia’s 1MDB fraud and Sam Bankman-Fried’s crypto scam
By Jane Lewis Published
-
Why undersea cables are under threat – and how to protect them
Undersea cables power the internet and are vital to modern economies. They are now vulnerable
By Simon Wilson Published
-
Share buybacks rise in the UK – what effect will it have?
Share buybacks are gaining popularity in the UK – good news for investors
By Rupert Hargreaves Published
-
Should you bet on US stocks?
You don’t have to be bearish on US stocks to worry that they are now such a large share of global indices
By Cris Sholto Heaton Published
-
Is now the time to buy Marshalls?
Former market darling Marshalls, a landscaping and building products supplier, looks too cheap. Is it time to buy this once-admired stock?
By Jamie Ward Published
-
Top UK stocks with healthy cash flows and dividend yields
Three promising UK stocks according to Alan Dobbie, co-manager, Rathbone Income Fund
By Alan Dobbie Published
-
Warren Buffet invests in Domino’s – should you buy?
What makes Domino's a compelling investment for Warren Buffet's Berkshire Hathaway, and should you buy the UK-listed takeaway pizza chain?
By Dr Matthew Partridge Published
-
Invest in Grainger: a landlord with growth potential
Grainger is putting years of uncertainty behind it and investing for expansion
By Rupert Hargreaves Published
-
UK equities are set for a bull market – buy now
Investors shouldn’t wait for a crisis to buy UK equities, says Max King. Do so now, in the expectation of much better returns in due course
By Max King Published